These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The Bone Marrow Microenvironment in Waldenström Macroglobulinemia. Jalali S; Ansell SM Hematol Oncol Clin North Am; 2018 Oct; 32(5):777-786. PubMed ID: 30190017 [TBL] [Abstract][Full Text] [Related]
4. Clinical application of genomics in Waldenström macroglobulinemia. Branagan AR; Lei M; Treon SP; Castillo JJ Leuk Lymphoma; 2021 Aug; 62(8):1805-1815. PubMed ID: 33569985 [TBL] [Abstract][Full Text] [Related]
5. Current approach to Waldenström Macroglobulinemia. Ravi G; Kapoor P Cancer Treat Res Commun; 2022; 31():100527. PubMed ID: 35149375 [TBL] [Abstract][Full Text] [Related]
6. Defining Lymphoplasmacytic Lymphoma: Does MYD88L265P Define a Pathologically Distinct Entity Among Patients With an IgM Paraprotein and Bone Marrow-Based Low-Grade B-Cell Lymphomas With Plasmacytic Differentiation? Fang H; Kapoor P; Gonsalves WI; Frederick LA; Viswanatha D; Howard MT; He R; Morice WG; McPhail ED; Greipp PT; Ansell SM; Kyle RA; Gertz MA; Paludo J; Abeykoon J; King RL Am J Clin Pathol; 2018 Jul; 150(2):168-176. PubMed ID: 29868855 [TBL] [Abstract][Full Text] [Related]
7. Management of Waldenström macroglobulinemia in 2020. Castillo JJ; Treon SP Hematology Am Soc Hematol Educ Program; 2020 Dec; 2020(1):372-379. PubMed ID: 33275726 [TBL] [Abstract][Full Text] [Related]
8. SOHO State of the Art Updates and Next Questions: Waldenström Macroglobulinemia - 2021 Update on Management and Future Directions. Thomas SK Clin Lymphoma Myeloma Leuk; 2022 Jun; 22(6):347-355. PubMed ID: 34980578 [TBL] [Abstract][Full Text] [Related]
9. Novel approaches to targeting MYD88 in Waldenström macroglobulinemia. Castillo JJ; Hunter ZR; Yang G; Treon SP Expert Rev Hematol; 2017 Aug; 10(8):739-744. PubMed ID: 28617062 [TBL] [Abstract][Full Text] [Related]
10. Bing-Neel syndrome: Two unexpected cases and a review of the literature. Van Cauwenberge MG; Depreter B; Dumoulin EN; Emmerechts J; Nollet F; Vanopdenbosch LJ J Neurol Sci; 2015 Sep; 356(1-2):19-26. PubMed ID: 26159625 [TBL] [Abstract][Full Text] [Related]
11. What is new in the treatment of Waldenstrom macroglobulinemia? Castillo JJ; Treon SP Leukemia; 2019 Nov; 33(11):2555-2562. PubMed ID: 31591468 [TBL] [Abstract][Full Text] [Related]